Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump
NCT01520545
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
153
Enrollment
INDUSTRY
Sponsor class
Conditions
Severe Spasticity
Interventions
DRUG:
Gablofen® 3 mg/mL (baclofen injection)
DEVICE:
SynchroMed® II Programmable Pump
Sponsor
Piramal Critical Care, Ltd.